Oscar Health
OSCR· Finance· Fiscal year ends in December
Janet Liang is the CEO of Oscar Health and was paid $10.4M in FY2025 (Dec).
Executives5
See all- 1Janet LiangPresident of Oscar InsuranceFY2025
- 2Mario SchlosserPresident of Technology and Chief Technology OfficerFY2025
- 3Adam McAnaneyChief Legal OfficerFY2025
- 4R. Scott BlackleyChief Financial OfficerFY2025
- 5Mark BertoliniChief Executive OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allOscar Health paid its 5 named executives $30.7M in total in FY2025 (Dec). CEO Janet Liang was paid $10.4M of that.
| Name | |||
|---|---|---|---|
| Janet LiangPresident of Oscar Insurance | Not disclosed | Not disclosed | |
| Mario SchlosserPresident of Technology and Chief Technology Officer | |||
| Adam McAnaneyChief Legal Officer | Not disclosed | Not disclosed | |
| R. Scott BlackleyChief Financial Officer | Not disclosed | ||
| Mark BertoliniChief Executive Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers15
See allThe FY2025 (Dec) proxy of Oscar Health names 15 peer companies for pay. Among Oscar Health and these peers, CEO pay was the lowest of 9 and total shareholder return was 8th highest of 9.
9th highest of 9in Oscar Health and its pay peers, FY2025 (Dec) by CEO pay:
8th highest of 9in Oscar Health and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board2
See all- David PlouffeDirector · 4 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
- Laura LangDirector · 3 yr on the boardIndependentAudit—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 22, 2026 | FY2025 |
| Annual report | 10-K | Feb 13, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 25, 2025 | FY2024 |
| Annual report | 10-K | Feb 20, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 25, 2024 | FY2023 |
| Annual report | 10-K | Feb 15, 2024 | FY2023 |
